Studies
Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics
Neoadjuvant Chemotherapy +/- Bevacizumab Pharmacogenomics
Request Access
Overview
Selected Publications (2)
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
H. Bear, G. Tang, P. Rastogi, et al.. (2012). The New England journal of medicine. Cited 460 times.
https://doi.org/10.1056/NEJMoa1111097
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
H. Bear, G. Tang, P. Rastogi, et al.. (2015). The Lancet. Oncology. Cited 137 times.
https://doi.org/10.1016/S1470-2045(15)00041-8
